Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Open Label Two Period Crossover Study To Investigate The Effects Of Multiple Oral Doses Of Filibuvir On The Steady State Pharmacokinetics Of Oral Contraceptive Steroids In Healthy Female Subjects.

Next Previous
Trial Profile

A Phase 1, Open Label Two Period Crossover Study To Investigate The Effects Of Multiple Oral Doses Of Filibuvir On The Steady State Pharmacokinetics Of Oral Contraceptive Steroids In Healthy Female Subjects.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 09 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Filibuvir (Primary) ; Ethinylestradiol/levonorgestrel
  • Indications Pregnancy; Viral infections
  • Focus Pharmacokinetics
  • Sponsors Pfizer

Most Recent Events

  • 28 Apr 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
  • 01 Feb 2011 Planned end date changed from Jan 2011 to Feb 2011 as reported by ClinicalTrials.gov.
  • 03 Jan 2011 Planned End Date changed from 1 Dec 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top